These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 872500)

  • 1. Physiologic disposition of nabilone, a cannabinol derivative, in man.
    Rubin A; Lemberger L; Warrick P; Crabtree RE; Sullivan H; Rowe H; Obermeyer BD
    Clin Pharmacol Ther; 1977 Jul; 22(1):85-91. PubMed ID: 872500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacology of nabilone, a cannabinol derivative.
    Lemberger L; Rowe H
    Clin Pharmacol Ther; 1975 Dec; 18(6):720-6. PubMed ID: 1204278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 11-hydroxy- 9 -tetrahydrocannabinol: pharmacology, disposition, and metabolism of a major metabolite of marihuana in man.
    Lemberger L; Crabtree RE; Rowe HM
    Science; 1972 Jul; 177(4043):62-4. PubMed ID: 5041775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and disposition of clarithromycin in man.
    Ferrero JL; Bopp BA; Marsh KC; Quigley SC; Johnson MJ; Anderson DJ; Lamm JE; Tolman KG; Sanders SW; Cavanaugh JH
    Drug Metab Dispos; 1990; 18(4):441-6. PubMed ID: 1976065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species specificity in the metabolism of nabilone. Relationship between toxicity and metabolic routes.
    Sullivan HR; Hanasono GK; Miller WM; Wood PG
    Xenobiotica; 1987 Apr; 17(4):459-68. PubMed ID: 3037806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A species comparison of the toxicity of nabilone, a new synthetic cannabinoid.
    Hanasono GK; Sullivan HR; Gries CL; Jordan WH; Emmerson JL
    Fundam Appl Toxicol; 1987 Aug; 9(2):185-97. PubMed ID: 2888699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of dose, route, and repeated dosing on the disposition and kinetics of tetrabromobisphenol A in male F-344 rats.
    Kuester RK; Sólyom AM; Rodriguez VP; Sipes IG
    Toxicol Sci; 2007 Apr; 96(2):237-45. PubMed ID: 17234645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of delta9-tetrahydrocannabinol in dogs.
    Garrett ER; Hunt CA
    J Pharm Sci; 1977 Mar; 66(3):395-407. PubMed ID: 845807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolism of delta 9-tetrahydrocannabinol and related cannabinoids in man.
    Wall ME; Perez-Reyes M
    J Clin Pharmacol; 1981; 21(S1):178S-189S. PubMed ID: 6271823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nabilone. A preliminary review of its pharmacological properties and therapeutic use.
    Ward A; Holmes B
    Drugs; 1985 Aug; 30(2):127-44. PubMed ID: 2863127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of 14C-estazolam in dogs and humans.
    Machinist JM; Bopp BA; Anderson DJ; Granneman GR; Sonders RC; Tolman K; Buchi K; Rollins D
    Xenobiotica; 1986 Jan; 16(1):11-20. PubMed ID: 2868576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition and metabolism of finasteride in dogs.
    Carlin JR; Christofalo P; Arison BH; Ellsworth RE; Rosegay A; Miller RR; Chiu SH; VandenHeuvel WJ
    Drug Metab Dispos; 1997 Jan; 25(1):100-9. PubMed ID: 9010636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of thymoxamine. II. Studies with 14C-thymoxamine in man.
    Vollmer KO; Poisson A
    Eur J Drug Metab Pharmacokinet; 1985; 10(1):71-6. PubMed ID: 3161739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism and disposition of ortho-benzyl-para-chlorophenol in male rats.
    Ridley WP; Sewall MR; Dietrich MW
    J Toxicol Environ Health; 1986; 18(2):267-83. PubMed ID: 3712489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The disposition and metabolism of a hypnotic benzodiazepine, quazepam, in the hamster and mouse.
    Hilbert J; Pramanik B; Symchowicz S; Zampaglione N
    Drug Metab Dispos; 1984; 12(4):452-9. PubMed ID: 6148212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic effects and physiologic disposition of delta 6a,10a dimethyl heptyl tetrahydrocannabinol (DMHP) in man.
    Lemberger L; McMahon R; Archer R; Matsumoto K; Rowe H
    Clin Pharmacol Ther; 1974 Apr; 15(4):380-6. PubMed ID: 4821441
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic disposition of isoxicam in man, monkey, dog, and rat.
    Borondy PE; Michniewicz BM
    Drug Metab Dispos; 1984; 12(4):444-51. PubMed ID: 6148211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism, pharmacokinetics, and excretion of a nonpeptidic substance P receptor antagonist, ezlopitant, in normal healthy male volunteers: characterization of polar metabolites by chemical derivatization with dansyl chloride.
    Prakash C; O'Donnell J; Khojasteh-Bakht SC
    Drug Metab Dispos; 2007 Jul; 35(7):1071-80. PubMed ID: 17431029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of labetalol by animals and man.
    Martin LE; Hopkins R; Bland R
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and metabolism of 14C isobytylnaphtyl acetic acid in rat.
    Jacquot C; Payan-Lepain E; Christen MO; Achtert G; Hausleiter HJ; Borchers F
    Eur J Drug Metab Pharmacokinet; 1989; 14(4):249-56. PubMed ID: 2633918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.